SCHEMBL9059999

SCHEMBL9059999

Cc1cccc(-c2ccccc2)c1NC(=N)N(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
ALDH1A1 P00352 3/20 0.39
HTT P42858 2/20 0.38
LMNA P02545 2/20 0.38
NPSR1 Q6W5P4 1/20 0.38
ESR2 Q92731 1/20 0.38
S1PR4 O95977 1/20 0.38
CXCR2 P25025 1/20 0.37
PDCD1 Q15116 1/20 0.37
CD274 Q9NZQ7 1/20 0.37
POLB P06746 1/20 0.36
MAPT P10636 3/20 0.35
KDM4E B2RXH2 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
TSHR P16473 1/20 0.35
GAA P10253 1/20 0.35
BLM P54132 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9537596 0.89 FABP4 (0.41) SMN1; SMN2MEN1KMT2AALDH1A1HTT
SCHEMBL9539853 0.81 HTR7 (0.38) SMN1; SMN2MEN1KMT2AALDH1A1LMNA
SCHEMBL9311252 0.77 FABP4 (0.49) SMN1; SMN2MEN1KMT2AALDH1A1HTT
SCHEMBL9059754 0.75 FABP4 (0.49) ALDH1A1HTTLMNAPOLBMAPT
SCHEMBL9311982 0.74 ALDH1A1 (0.44) SMN1; SMN2KMT2AALDH1A1HTTLMNA
SCHEMBL9060479 0.73 POLB (0.45) SMN1; SMN2ALDH1A1LMNAPOLBMAPT
SCHEMBL9059153 0.73 KDM4E (0.44) MEN1KMT2AALDH1A1LMNAPOLB
SCHEMBL18509790 0.72 ESR2 (0.42) SMN1; SMN2ALDH1A1HTTLMNANPSR1
SCHEMBL16351359 0.72 ALDH1A1 (0.47) SMN1; SMN2ALDH1A1HTTLMNANPSR1
SCHEMBL2760768 0.71 ALDH1A1 (0.51) SMN1; SMN2MEN1KMT2AALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996017612-A1 USE OF SUBSTITUTED PHENYLAMIDINE AND PHENYLGUANIDINE COMPOUNDS FOR THE TREATMENT OF CEREBRAL AND CARDIAC ISCHAEMIA, CONVULSION AND SICKLE CELL ANAEMIA KNOLL AKTIENGESELLSCHAFT (DE) 1996-06-13 WO disclosed
EP-0536151-B1 ORTHOSUBSTITUTED BIPHENYL GUANIDINE DERIVATIVES AND ANTIDIABETIC OR HYPOGLYCAEMIC AGENTS CONTAINING THEM BOOTS CO PLC (GB) 1994-09-14 EP disclosed
US-5302720-A Biphenyl-substituted guanidine derivatives useful as hypoglycaemic agents THE BOOTS COMPANY (GB) 1994-04-12 US disclosed
EP-0536151-A1 ORTHOSUBSTITUTED BIPHENYL GUANIDINE DERIVATIVES AND ANTIDIABETIC OR HYPOGLYCAEMIC AGENTS CONTAINING THEM. BOOTS CO PLC (GB) 1993-04-14 EP disclosed
WO-1992000273-A1 ORTHOSUBSTITUTED BIPHENYL AMIDINE AND BIPHENYL GUANIDINE DERIVATIVES AND ANTIDIABETIC OR HYPOGLYCAEMIC AGENTS CONTAINING THEM THE BOOTS COMPANY PLC (GB) 1992-01-09 WO disclosed